AVORO CAPITAL ADVISORS LLC 13D/13G Filings for Avadel Pharmaceuticals plc (AVDL)

AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Avadel Pharmaceuticals plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-11
10:07 am
Sale
2021-12-31 13G Avadel Pharmaceuticals plc
AVDL
AVORO CAPITAL ADVISORS LLC 1,670,000
2.900%
-2,695,000decrease
(-61.74%)
Filing
2021-02-12
08:07 am
Purchase
2020-12-31 13G Avadel Pharmaceuticals plc
AVDL
AVORO CAPITAL ADVISORS LLC 4,365,000
7.500%
4,365,000increase
(New Position)
Filing